Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 9, 2007, Pages 3366-3371

  Rowe, Martin ^a   Glaunsinger, Britt ^b,e   Van Leeuwen, Daphne ^c   Zuo, Jianmin ^a   Sweetman, David ^a   Ganem, Don ^b   Middeldorp, Jaap ^d   Wiertz, Emmanuel J H J ^c   Ressing, Maaike E ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Herpesvirus; HLA; Immune escape; RNA degradation

Indexed keywords

GENE PRODUCT; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MESSENGER RNA; PROTEIN BGLF5; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOLYSIS; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN HERPESVIRUS 8; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RAT; RNA DEGRADATION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL LINE, TUMOR; DEOXYRIBONUCLEASES; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICROSCOPY, FLUORESCENCE; PROTEIN BIOSYNTHESIS; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 33847615627     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0611128104     Document Type: Article

References (39)

1. Rickinson AB, Kieff E (2001) in Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), pp 2575-2627.
2. Amyes E, Hatton C, Montamat-Sicotte D, Gudgeon N, Rickinson AB, McMichael AJ, Callan MF (2003) J Exp Med 198:903-911.
3. Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB (2002) J Exp Med 195:893-905.
4. Yao QY, Rickinson AB, Epstein MA (1985) Int J Cancer 35:35-42.
5. Roizman B, Pellet PE (2001) in Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), pp 2381-2397.
6. Koppers-Lalic D, Rijsewijk FA, Verschuren SB, van Gaans-Van den Brink JA, Neisig A, Ressing ME, Neefjes J, Wiertz EJ (2001) J Gen Virol 82:2071-2081.
7. Smiley JR (2004) J Virol 78:1063-1068.
8. Tigges MA, Leng S, Johnson DC, Burke RL (1996) J Immunol 156:3901-3910.
9. Lilley BN, Ploegh HL (2005) Immunol Rev 207:126-144.
10. Ressing ME, van Leeuwen D, Verreck FA, Gomez R, Heemskerk B, Toebes M, Mullen MM, Jardetzky TS, Longnecker R, Schilham MW, et al. (2003) Proc Natl Acad Sci USA 100:11583-11588.
11. Ressing ME, van Leeuwen D, Verreck FA, Keating S, Gomez R, Franken KL, Ottenhoff TH, Spriggs M, Schumacher TN, Hutt-Fletcher LM, et al. (2005) J Virol 79:841-852.
12. Ressing ME, Keating SE, van Leeuwen D, Koppers-Lalic D, Pappworth IY, Wiertz EJ, Rowe M (2005) J Immunol 174:6829-6838.
13. Keating S, Prince S, Jones M, Rowe M (2002) J Virol 76:8179-8188.
14. Taddeo B, Zhang WR, Roizman B (2006) Proc Natl Acad Sci USA 103:2827-2832.
15. Glaunsinger B, Ganem D (2004) Mol Cell 13:713-723.
16. Glaunsinger B, Ganem D (2004) J Exp Med 200:391-398.
17. Glaunsinger B, Chavez L, Ganem D (2005) J Virol 79:7396-7401.
18. Knopf CW, Weisshart K (1990) Eur J Biochem 191:263-273.
19. Reuven NB, Antoku S, Weller SK (2004) J Virol 78:4599-4608.
20. Sheaffer AK, Weinheimer SP, Tenney DJ (1997) J Gen Virol 78:2953-2961.
21. Daibata M, Sairenji T (1993) Virology 196:900-904.
22. Liu MT, Hu HP, Hsu TY, Chen JY (2003) J Gen Virol 84:677-686.
23. Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ (2000) Proc Natl Acad Sci USA 97:8455-8460.
24. Kwong AD, Frenkel N (1987) Proc Natl Acad Sci USA 84:1926-1930.
25. Sandri-Goldin RM (2004) J Virol 78:4389-4396.
26. Gruffat H, Batisse J, Pich D, Neuhierl B, Manet E, Hammerschmidt W, Sergeant A (2002) J Virol 76:9635-9644.
27. Ruvolo V, Wang EY, Boyle S, Swaminathan S (1998) Proc Natl Acad Sci USA 95:8852-8857.
28. Ruvolo V, Sun L, Howard K, Sung S, Delecluse HJ, Hammerschmidt W, Swaminathan S (2004) J Virol 78:340-352.
29. Heller KN, Gurer C, Munz C (2006) J Exp Med 203:805-808.
30. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y (1995) Nature 375:415-418.
31. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D (1995) Nature 375:411-415.
32. Koppers-Lalic D, Reits EA, Ressing ME, Lipinska AD, Abele R, Koch J, Marcondes RM, Admiraal P, van Leeuwen D, Bienkowska-Szewczyk K, et al. (2005) Proc Natl Acad Sci USA 102:5144-5149.
33. Coscoy L, Ganem D (2000) Proc Natl Acad Sci USA 97:8051-8056.
34. Ishido S, Wang CY, Lee BS, Cohen GB, Jung JU (2000) J Virol 74:5300-5309.
35. Mocarski ES, Courcelle CT (2001) in Fields Virology, eds Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Strauss SE (Lippincott Williams & Wilkins, New York), pp 2629-2674.
36. Geiss BJ, Smith TJ, Leib DA, Morrison LA (2000) J Virol 74:11137-11144.
37. Smith TJ, Ackland-Berglund CE, Leib DA (2000) J Virol 74:3598-3604.
38. Strelow LI, Leib DA (1995) J Virol 69:6779-6786.
39. York IA, Roop C, Andrews DW, Riddell SR, Graham FL, Johnson DC (1994) Cell 77:525-535.